RIL
DYN icon

Rothschild Investment LLC’s Dyne Therapeutics DYN Stock Holding History

Rothschild Investment LLC’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66K Hold
210
– – ﹤0.01% 2312
2026
Q1 		$3.81K Buy
210
+40
+24% +$690 ﹤0.01% 2203
2025
Q4 		$3.33K Buy
170
+5
+3% +$95 ﹤0.01% 2105
2025
Q3 		$2.09K Buy
165
+40
+32% +$456 ﹤0.01% 2206
2025
Q2 		$1.19K Buy
125
+35
+39% +$385 ﹤0.01% 2370
2025
Q1 		$941 Buy
90
+30
+50% +$429 ﹤0.01% 2378
2024
Q4 		$1.41K Sell
60
-30
-33% -$887 ﹤0.01% 2016
2024
Q3 		$3.23K Buy
90
+55
+157% +$2.19K ﹤0.01% 1471
2024
Q2 		$1.24K Buy
35
+30
+600% +$872 ﹤0.01% 1556
2024
Q1 		$142 Buy
+5
New +$113 ﹤0.01% 1948

Other funds holding DYN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rothschild Investment LLC's DYN Position: Q2 2026 in Review

Rothschild Investment LLC held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 210 shares worth $4.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2312.

Rothschild Investment LLC first reported a position in DYN in Q1 2024 and has held it in 10 quarters since. 76 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Rothschild Investment LLC held 210 shares of Dyne Therapeutics worth $4.66K as of Q2 2026.
  • Rothschild Investment LLC left its Dyne Therapeutics share count unchanged in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2312 holding.
  • Rothschild Investment LLC first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 76 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.